Covered recipient · General Payments record
DANIEL D MOSEL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,805.84
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $497.49 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $191.90 | 12 |
| Lilly USA, LLC | $136.57 | 7 |
| E.R. Squibb & Sons, L.L.C. | $55.03 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.82 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $20.99 | 1 |
| Janssen Biotech, Inc. | $18.07 | 1 |
| PFIZER INC. | $16.95 | 1 |
| Amgen Inc. | $16.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.12 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071201 | CMS |
| ABBVIE INC. | $8.00 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071203 | CMS |
| ABBVIE INC. | $23.75 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071205 | CMS |
| ABBVIE INC. | $6.60 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071207 | CMS |
| ABBVIE INC. | $22.76 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071209 | CMS |
| ABBVIE INC. | $3.09 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071211 | CMS |
| ABBVIE INC. | $14.46 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071213 | CMS |
| ABBVIE INC. | $34.79 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071215 | CMS |
| ABBVIE INC. | $17.27 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071217 | CMS |
| ABBVIE INC. | $18.53 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071219 | CMS |
| ABBVIE INC. | $14.94 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071221 | CMS |
| ABBVIE INC. | $19.59 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105071223 | CMS |
| Amgen Inc. | $16.16 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333472 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.25 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101374860 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.20 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101374990 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.58 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101375024 | CMS |
| Janssen Biotech, Inc. | $18.07 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078338105 | CMS |
| Lilly USA, LLC | $17.83 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119530 | CMS |
| Lilly USA, LLC | $18.72 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136140973 | CMS |
| Lilly USA, LLC | $24.93 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136129246 | CMS |
| Lilly USA, LLC | $15.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136140975 | CMS |
| Lilly USA, LLC | $24.03 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119532 | CMS |
| Lilly USA, LLC | $15.33 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119384 | CMS |
| Lilly USA, LLC | $20.73 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136133403 | CMS |
| Novartis Pharmaceuticals Corporation | $24.37 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087091934 | CMS |
| Novartis Pharmaceuticals Corporation | $17.45 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087091944 | CMS |
| PFIZER INC. | $16.95 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132119980 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $20.99 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152140009 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.